Compartmental immunophenotyping in COVID-19 ARDS: A case series

  title={Compartmental immunophenotyping in COVID-19 ARDS: A case series},
  author={Andreas Ronit and Ronan M.G. Berg and Jakob T Bay and Anna Karen Haugaard and Magnus Glindvad Ahlstr{\"o}m and Kristoffer S Burgdorf and Henrik Ullum and Sara B. R{\o}rvig and Klaus Tjelle and Nicolai Bang Foss and Thomas Lars Benfield and Hanne Vibeke Marquart and Ronni R. Plovsing},
  journal={The Journal of Allergy and Clinical Immunology},
  pages={81 - 91}
  • A. Ronit, R. Berg, R. Plovsing
  • Published 23 September 2020
  • Medicine, Biology
  • The Journal of Allergy and Clinical Immunology

Figures and Tables from this paper

Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients

In critically ill COVID-19 patients, bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome was identified.

COVID-19: Lung-Centric Immunothrombosis

Evidence in favor of a lung-centric immunothrombosis is addressed and a lung/lung-centric therapeutic approach to the ARDS of COVID-19 is suggested.

Immunothrombosis in Acute Respiratory Dysfunction of COVID-19

The current manuscript will describe the proinflammatory milieu in COVID-19, summarize current evidence of thrombosis in CoV-2, and discuss possible interactions between these two.

Complex Immune Dysregulation in COVID-19 and Implications for Treatment

The lack of homogeneity in clinical efficacy in severe COVID-19 underlines the need to follow a strategy of personalized treatment guided by biomarkers.

Haemophagocytic syndrome and COVID-19

In COVID-19 patients presenting with persistent high fever, progressive pancytopenia, and hepatosplenic involvement, the suspicion of HLH is high, and the diagnostic workup must be completed with specific immunological and histopathological studies.

A unique dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients

DXM treatment was not associated withregulation of pro-inflammatory pathways in CARDS but with regulation of other specific local innate and adaptive immune responses, challenging the concept of a COVID-19 specific cytokine storm.

The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment

The current understanding of the change of Tregs in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is reviewed and the proposed Treg-targeted therapies, including both adoptive Treg transfer and low dose of IL-2 treatment, are introduced.

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome

An impaired production of type I and III interferons in response to SARS-CoV-2 infection is observed and several rare potentially disease-causing gene variants potentially contributing to MIS-A are detected.

The signal pathways and treatment of cytokine storm in COVID-19

It is believed that a comprehensive understanding of CS in COVID-19 will help to develop better strategies to effectively control immunopathology in this disease and other infectious and inflammatory diseases.

Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury

The paracrine production and viability of the three leading cell products under clinical evaluation for the treatment of severe COVID-19 ARDS are not altered by inflammatory mediators implicated in disease progression.



Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Single-cell transcriptome and T cell receptor analysis of bronchoalveolar lavage fluid suggests enrichment of proinflammatory macrophages in patients with severe COVID-19 and the presence of clonally expanded CD8 + T cells in Patients with moderate CO VID-19.

Eosinophil responses during COVID-19 infections and coronavirus vaccination

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.

In this small series, vascular angiogenesis distinguished the pulmonary pathobiology of Covid-19 from that of equally severe influenza virus infection.

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia

Data indicate that Th 17 cells are engaged in the local and systemic immune response in human pneumonia, especially, IL-17A/IL-22 double positive Th17 cells may be involved in the immunopathogenesis of CAP.

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

The high incidence of thromboembolic events suggests an important role of COVID-19–induced coagulopathy, as well as possible therapeutic interventions to reduce it, in patients dying with a polymerase chain reaction–confirmed diagnosis of CO VID-19.

COVID-19 with Different Severities: A Multicenter Study of Clinical Features

  • Yun FengY. Ling J. Qu
  • Medicine
    American journal of respiratory and critical care medicine
  • 2020
Multiple organ dysfunction and impaired immune function were the typical characteristics of patients with severe or critical illness and there was a significant difference in the use of angiotensin-converting enzyme inhibitors/angiotens in II receptor blockers among patients with different severities of disease.

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

In patients hospitalized with COVID-19, dexamethasone reduced 28-day mortality among those receiving invasive mechanical ventilation or oxygen at randomization, but not among patients not receiving respiratory support.

Bronchoalveolar lavage cell pattern from healthy human lung

The data suggest that age corrected BAL fluid CD4+/CD8+ ratios should be used in the clinical evaluation of patients with interstitial lung diseases.

Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis

Abnormal haematological variables were common among patients with SARS and the depletion of T lymphocyte subsets may be associated with disease activity.